Diamyd Medical's registrational Phase 3 trial in type 1 diabetes, has now exceeded 290, and the screening will conclude in the coming weeks. The interim ...

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

Biocon Limited ( ($IN:BIOCON) ) has shared an announcement. Biocon Limited announced that the U.S. FDA has classified its Biocon Biologics’ Drug ...

Artificial Food Dyes Making America Colorful But Controversial Let me tell you something that might completely change how you look at your breakfast cereal tomorrow morning. S. Food and Drug ...

Scientists have successfully transplanted gene-edited insulin-producing cells into a man with type 1 diabetes—allowing him to ...

Understanding how the cells that control blood sugar work is crucial to preventing and treating diabetes. Researchers at Karolinska Institutet have now developed a technique that makes it possible to ...

Researchers from the Institute of Genetics and Developmental Biology of the Chinese Academy of Sciences (CAS) have uncovered ...

From saccharin in the 19th century to stevia and monk fruit in the 21st, researchers and the food industry have long sought a ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged. Study: Effect of metformin on insulin ...